Reaction
Foaming At Mouth reporting signals
As of the last recalculation, Foaming At Mouth appears in 1,988 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is IOHEXOL (PRR 20.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Iohexol | 16 | 20.4 | 20.4 |
| Trimethoprim | 18 | 16.1 | 16.1 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 13 | 12.4 | 12.4 |
| Memantine | 14 | 10.8 | 10.8 |
| Memantine Hydrochloride | 14 | 10.8 | 10.8 |
| Felodipine Extended-Release Tablets | 10 | 9.2 | 9.2 |
| Felodipine | 10 | 9.2 | 9.2 |
| Desloratadine | 9 | 8.8 | 8.8 |
| Lithium | 21 | 8.8 | 8.8 |
| Lithium Bromatum | 21 | 8.8 | 8.8 |
| Ethyl Alcohol | 19 | 7.4 | 7.4 |
| Sertraline | 78 | 7.2 | 7.2 |
| Isopropyl Alcohol | 21 | 6.6 | 6.6 |
| Donepezil Hydrochloride | 22 | 6.3 | 6.3 |
| Alcohol | 20 | 5.4 | 5.4 |
| Nicotine Polacrilex | 19 | 5.2 | 5.2 |
| Asenapine Maleate | 4 | 4.8 | 4.8 |
| Methadone Hydrochloride | 4 | 3.9 | 3.9 |
| Sevelamer Carbonate | 4 | 3.7 | 3.7 |
| Siponimod | 3 | 3.5 | 3.5 |
| Lurasidone Hydrochloride | 7 | 3.5 | 3.5 |
| Palivizumab | 5 | 3.4 | 3.4 |
| Agalsidase Beta | 3 | 3.4 | 3.4 |
| Cetuximab | 10 | 3.4 | 3.4 |
| Tafamidis | 3 | 2.7 | 2.7 |
| Vigabatrin | 3 | 2.2 | 2.2 |
| Valbenazine | 5 | 2.1 | 2.1 |